Internet-delivered CBT for Children With Functional Gastrointestinal Disorders - an Open Pilot Study
Internet-delivered Cognitive Behavior Therapy for Children With Pain-predominant Functional Gastrointestinal Disorders - an Open Pilot Study
1 other identifier
interventional
31
1 country
2
Brief Summary
This pilot-study aims to evaluate the effect size and feasibility of internet-delivered cognitive behavior therapy (ICBT) for children (age 8-12 years) with pain-predominant functional gastrointestinal disorders (e.g. irritable bowel syndrome, functional abdominal pain and functional dyspepsia according to the Rome III criteria). The main component investigated in this study is exposure for gastrointestinal symptoms and for feared stimuli and situations. Children will participate along with one of their parents in the treatment. The parents will also receive specific modules with information on how to support their child in the treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2015
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2015
CompletedFirst Posted
Study publicly available on registry
June 18, 2015
CompletedStudy Start
First participant enrolled
July 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedMarch 3, 2017
March 1, 2017
1.3 years
June 15, 2015
March 2, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
PedsQL Gastro
Change in gastrointestinal symptoms measured with a self-rating scale from baseline to 10 weeks, and from baseline to 9 months for analysis of effect.
Baseline to 10 weeks, baseline to 9 months
Secondary Outcomes (24)
Faces Pain Rating Scale. (FACES)
Baseline to 10 weeks, baseline to 9 months
Faces Pain Rating Scale. (FACES)
Weekly during treatment (treatment week 1-9)
The Pain App
Baseline to 10 weeks, baseline to 9 months
Pediatric Quality of Life Inventory (PedsQL)
Baseline to 10 weeks, baseline to 9 months
Children´s Somatization Inventory (CSI 24)
Baseline to 10 weeks, baseline to 9 months
- +19 more secondary outcomes
Study Arms (1)
Internet-delivered CBT
EXPERIMENTALChildren and parents will receive 10 weekly modules of internet-delivered CBT (Cognitive Behavior Therapy). Parents will also receive 10 weekly specific modules for parents. Main components in the modules directed at children and parents are exposure for symptoms, feared stimuli and situations. The parents modules contain information on how they can support their children in the treatment and is based on social learning theory. Therapist support is provided through written messages within the secure platform. Therapists are trained CBT-psychologists.
Interventions
The treatment is based on an internet-delivered CBT-treatment for adults with IBS and on the adapted version for adolescents with functional gastrointestinal disorders. The protocol has been tested in an open face-to-face CBT study of children aged 8-12 years (n=20) with promising results. Main component in the treatment is exposure for symptoms. The purpose of the treatment is to reduce fearful and anxious responses to symptoms and lessen avoidance of symptoms in the child, and to teach the parents how parental behavior can influence symptoms in children as well as how to support exposure. Detailed behaviour analysis is made for each individual and instruction is given on how to gradually expose to symptoms to lessen fear for symptoms and widen the behavioral repertoire.
Eligibility Criteria
You may qualify if:
- Children between 8-12 years (until their 13th birthday) who have been diagnosed with any of the diagnoses irritable bowel syndrome, functional dyspepsia or functional abdominal pain according to the Rome III criteria.
- Any psychopharmacological medication should be stable since 1 month.
- Parents and children need to master Swedish, have access to a computer with internet access, and be willing to participate in 10 weeks of treatment with homework.
You may not qualify if:
- Simultaneous presence of serious somatic disease and / or if the child meets the criteria for other organic disease which better explains the symptoms.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Child and Adolescent Psychiatry in Stockholm
Stockholm, Stockholms Lans Landsting, 11330, Sweden
Child and Adolescent Psychiatry in Stockholm
Stockholm, 11330, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ola Olén, MD PhD
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD MD
Study Record Dates
First Submitted
June 15, 2015
First Posted
June 18, 2015
Study Start
July 1, 2015
Primary Completion
November 1, 2016
Study Completion
November 1, 2016
Last Updated
March 3, 2017
Record last verified: 2017-03